PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
+5.51%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$16.1B
AUM Growth
+$727M
(+4.7%)
Cap. Flow
+$462M
Cap. Flow
% of AUM
2.87%
Top 10 Holdings %
Top 10 Hldgs %
26.88%
Holding
375
New
58
Increased
118
Reduced
105
Closed
56
Top Buys
| 1 |
Micron Technology
MU
|
+$173M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$142M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$141M |
| 4 |
Guardant Health
GH
|
+$106M |
| 5 |
Applied Materials
AMAT
|
+$102M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$158M |
| 2 |
Advanced Micro Devices
AMD
|
+$140M |
| 3 |
Amazon
AMZN
|
+$131M |
| 4 |
Humana
HUM
|
+$90.9M |
| 5 |
Axon Enterprise
AXON
|
+$86.1M |
Sector Composition
| 1 | Technology | 35.49% |
| 2 | Healthcare | 19.84% |
| 3 | Financials | 16.96% |
| 4 | Communication Services | 14.54% |
| 5 | Consumer Discretionary | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANSS
101
DELISTED
Ansys
ANSS
| $40.8M | 0.25% |
120,114
-1,217
| -1% | -$413K |
|
102
Cooper Companies
COO
$13.3B
| $40.2M | 0.25% |
+419,152
| New | +$40.2M |
|
103
Option Care Health
OPCH
$4.62B
| $39.7M | 0.25% |
2,239,506
| – | – |
|
|
MODV
104
DELISTED
ModivCare
MODV
| $39.3M | 0.24% |
+265,166
| New | +$39.3M |
|
|
AVLR
105
DELISTED
Avalara, Inc.
AVLR
| $39.1M | 0.24% |
292,697
-136,282
| -32% | -$18.2M |
|
106
T-Mobile US
TMUS
$272B
| $38.7M | 0.24% |
308,842
+86,508
| +39% | +$10.8M |
|
107
Haemonetics
HAE
$2.51B
| $37.6M | 0.23% |
338,576
+49,486
| +17% | +$5.49M |
|
108
Citigroup
C
$183B
| $37.6M | 0.23% |
516,566
-40,228
| -7% | -$2.93M |
|
109
Cognex
CGNX
$7.45B
| $37.6M | 0.23% |
452,559
+51,256
| +13% | +$4.25M |
|
110
Elevance Health
ELV
$70.2B
| $37.3M | 0.23% |
104,000
+10,778
| +12% | +$3.87M |
|
|
CCXI
111
DELISTED
ChemoCentryx, Inc.
CCXI
| $36.8M | 0.23% |
718,804
+137,610
| +24% | +$7.05M |
|
112
eBay
EBAY
$41.5B
| $36.6M | 0.23% |
597,608
+489,023
| +450% | +$29.9M |
|
113
Summit Therapeutics
SMMT
$14.1B
| $36.2M | 0.22% |
6,158,800
+358,800
| +6% | +$2.11M |
|
114
US Foods
USFD
$17.9B
| $35.8M | 0.22% |
938,673
+124,047
| +15% | +$4.73M |
|
115
Regeneron Pharmaceuticals
REGN
$59.4B
| $35.5M | 0.22% |
75,000
-20,000
| -21% | -$9.46M |
|
|
ALXN
116
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $34.4M | 0.21% |
225,000
-275,000
| -55% | -$42.1M |
|
|
QTNT
117
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $34M | 0.21% |
231,291
| – | – |
|
118
First American
FAF
$6.87B
| $34M | 0.21% |
600,000
| – | – |
|
119
AtriCure
ATRC
$1.74B
| $33.3M | 0.21% |
507,986
+96,010
| +23% | +$6.29M |
|
120
James River Group
JRVR
$244M
| $33.1M | 0.2% |
725,000
| – | – |
|
|
NSTG
121
DELISTED
NanoString Technologies, Inc.
NSTG
| $32.9M | 0.2% |
500,000
+250,000
| +100% | +$16.4M |
|
122
Surgery Partners
SGRY
$2.8B
| $32.7M | 0.2% |
738,826
-60,228
| -8% | -$2.67M |
|
|
RVNC
123
DELISTED
Revance Therapeutics, Inc.
RVNC
| $32.3M | 0.2% |
1,154,734
| – | – |
|
124
ProAssurance
PRA
$1.22B
| $32.1M | 0.2% |
1,200,000
| – | – |
|
125
Insmed
INSM
$30.8B
| $31.9M | 0.2% |
936,438
+235,137
| +34% | +$8.01M |
|